Cenobamate for treatment-resistant focal seizures: current evidence and place in therapy.

Based on the findings of these trials, cenobamate seems to be an attractive option for treatment-resistant partial-onset seizures; however, multiple treatment-related adverse effects and drug-drug interactions are the areas of concern.